BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Lei M, Yan LN, Yang JY, Wen TF, Li B, Wang WT, Wu H, Xu MQ, Chen ZY, Wei YG. Safety of hepatitis B virus core antibody-positive grafts in liver transplantation: A single-center experience in China. World J Gastroenterol 2018; 24(48): 5525-5536 [PMID: 30622380 DOI: 10.3748/wjg.v24.i48.5525]
URL: https://www.wjgnet.com/2307-8960/full/v24/i48/5525.htm
Number Citing Articles
1
Brad Busebee, Laura Myhre, Kristin Mara, Bashar Aqel, Timucin Taner, Kymberly D. Watt. De novo hepatitis B infection following liver transplantation with core antibody positive grafts: The role of surface antibody status in guiding long‐term prophylaxisClinical Transplantation 2024; 38(2) doi: 10.1111/ctr.15263
2
Peng‐sheng Ting, James Peter Hamilton, Ahmet Gurakar, Nathalie H. Urrunaga, Michelle Ma, Jaime Glorioso, Elizabeth King, Lindsey P. Toman, Russell Wesson, Jacqueline Garonzik‐Wang, Shane Ottmann, Benjamin Philosophe, Mark Sulkowski, Andrew M. Cameron, Christine M. Durand, Po‐Hung Chen. Hepatitis C‐positive donor liver transplantation for hepatitis C seronegative recipientsTransplant Infectious Disease 2019; 21(6) doi: 10.1111/tid.13194
3
Myra Nasir, George Y. Wu. Prevention of HBV Recurrence after Liver Transplant: A ReviewJournal of Clinical and Translational Hepatology 2020; 8(2): 150 doi: 10.14218/JCTH.2020.00003
4
Si-Long Gao, Bao-Ying Mou, De-Shu Dai, Li Han, Sheng-Bao Zhao, Chuan-Shen Xu, Xiao Xu, Jin-Zhen Cai. Marginal donor liver versus standard donor liver: A single-center observational studyHepatobiliary & Pancreatic Diseases International 2023; 22(3): 239 doi: 10.1016/j.hbpd.2022.10.005
5
Pankaj Puri, Abhinav Kumar, Mohd Qaleem. Donor Evaluation Protocol for Live and Deceased DonorsJournal of Clinical and Experimental Hepatology 2024; 14(1): 101217 doi: 10.1016/j.jceh.2023.07.004
6
Kali Zhou, Selena Zhou. Risk of disease transmission in an expanded donor population: the potential of hepatitis B virus donorsCurrent Opinion in Organ Transplantation 2020; 25(6): 631 doi: 10.1097/MOT.0000000000000810
7
Madeleine S. Tilley, Taylor L. Sparkman, Alexandra P. James, Peng Li, Kristofer C. Gutierrez. Hepatitis B prophylaxis among recipients of a hepatitis B core antibody positive liver transplantJournal of the American Pharmacists Association 2023; 63(4): S69 doi: 10.1016/j.japh.2023.01.009
8
Kyeong Deok Kim, Ji Eun Lee, Jong Man Kim, Okjoo Lee, Na Young Hwang, Jinsoo Rhu, Gyu-Seong Choi, Kyunga Kim, Jae-Won Joh. Cost-effectiveness and long-term outcomes of liver transplantation using hepatitis B core antibody-positive grafts with hepatitis B immunoglobulin prophylaxis in KoreaClinical and Molecular Hepatology 2021; 27(4): 603 doi: 10.3350/cmh.2021.0137
9
James S. Park, Vijay Gayam, Calvin Q. Pan. Review article: preventing hepatitis B graft infection in hepatitis B patients after liver transplantation: immunoglobulin vs anti‐viralsAlimentary Pharmacology & Therapeutics 2020; 52(6): 944 doi: 10.1111/apt.15999
10
Robert G. Gish, Syed Abdul Basit, John Ryan, Altaf Dawood, Ulrike Protzer. Hepatitis B Core Antibody: Role in Clinical Practice in 2020Current Hepatology Reports 2020; 19(3): 254 doi: 10.1007/s11901-020-00522-0